Process for preparing ruthenium-phosphine complex
    1.
    发明授权
    Process for preparing ruthenium-phosphine complex 失效
    制备钌膦配合物的方法

    公开(公告)号:US5919962A

    公开(公告)日:1999-07-06

    申请号:US933973

    申请日:1997-09-19

    CPC分类号: C07F15/0053

    摘要: Disclosed is a ruthenium-phosphine complex represented by formula (I):�{RuX(L)}.sub.2 (.mu.-X).sub.3 !.sup.- �R.sub.2 NH.sub.2 !.sup.+(I)wherein R is hydrogen, an alkyl group having 1 to 5 carbon atoms, a cycloalkyl group, a substituted or unsubstituted phenyl group or a substituted or unsubstituted benzyl group; X is halogen; and L is an optically active or inactive tertiary phosphine. A process for preparing the complex (I) is also disclosed, which comprises (A) reacting a ruthenium complex represented by formula: �RuX(arene)(L)!X (wherein arene is a substituted or unsubstituted phenyl group) and an ammonium salt represented by formula (III): R.sub.2 NH.HX, or (B) reacting a ruthenium complex represented by formula: �RuX.sub.2 (arene)!.sub.2, a tertiary phosphine represented by L, and an ammonium salt (III). The complex (I) useful as a catalyst for general syntheses or asymmetric syntheses can be obtained easily in good yield.

    摘要翻译: 公开了由式(I)表示的钌膦配合物:[{RuX(L)} 2(mu -X)3] - [R 2 NH 2] +(I)其中R是氢,具有1至5个碳原子的烷基 原子,环烷基,取代或未取代的苯基或取代或未取代的苄基; X是卤素; L是光学活性或无活性的叔膦。 还公开了制备络合物(I)的方法,其包括(A)使由式[RuX(芳烃)(L)] X(其中芳烃为取代或未取代的苯基)和铵 由式(III)表示的盐:R2NH.HX,或(B)使由式[RuX2(芳烃)] 2表示的钌络合物,由L表示的叔膦和铵盐(III)反应。 可以容易地以良好的收率获得用作一般合成或不对称合成的催化剂的络合物(I)。

    Condensation Reaction by Metal Catalyst
    6.
    发明申请
    Condensation Reaction by Metal Catalyst 有权
    金属催化剂的缩合反应

    公开(公告)号:US20090198070A1

    公开(公告)日:2009-08-06

    申请号:US12085988

    申请日:2006-12-04

    摘要: The invention relates to a method for producing an azoline compound represented by the general formula (3): wherein R1 represents an optionally substituted hydrocarbon group, an optionally substituted alkoxy group, an optionally substituted alkoxycarbonyl group, a halogen atom, a substituted amino group, a substituted carbamoyl group or an optionally substituted heterocyclic group; R3, R4, R5 and R6 may be the same or different and each represents a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted alkoxy group, an optionally substituted alkoxycarbonyl group, a halogen atom, a substituted amino group, a substituted carbamoyl group or an optionally substituted heterocyclic group; two arbitrary groups selected from R3, R4, R5 and R6 may bond to each other to form a ring; and Z1 represents an oxygen atom, a sulfur atom or a selenium atom; comprising reacting a carboxylic acid or a carboxylic acid derivative represented by the general formula (1): R1CO2R2  (1) wherein R1 is as defined above; R2 represents a hydrogen atom, an optionally substituted alkyl group or an optionally substituted aryl group; and R1 and R2 may bond to each other to form a ring; with an aminochalcogenide represented by the general formula (2): wherein R3, R4, R5, R6 and Z1 are as defined above; in the presence of a compound containing a group 12 metal element in the periodic table.

    摘要翻译: 本发明涉及一种制备由通式(3)表示的唑啉化合物的方法:其中R1表示任选取代的烃基,任选取代的烷氧基,任选取代的烷氧基羰基,卤素原子,取代的氨基, 取代的氨基甲酰基或任选取代的杂环基; R3,R4,R5和R6可以相同或不同,各自表示氢原子,任选取代的烃基,任选取代的烷氧基,任选取代的烷氧基羰基,卤素原子,取代的氨基,取代的氨基甲酰基 基团或任选取代的杂环基团; 选自R3,R4,R5和R6中的两个任意基团可以彼此键合形成环; Z1表示氧原子,硫原子或硒原子; 包括使由通式(1)表示的羧酸或羧酸衍生物反应:<?in-line-formula description =“In-line formula”end =“lead”?> R1CO2R2(1)<? -formulae description =“In-line Formulas”end =“tail”?>其中R1如上定义; R2表示氢原子,任选取代的烷基或任选取代的芳基; 并且R 1和R 2可以彼此键合形成环; 与通式(2)表示的氨基硫族化物:其中R3,R4,R5,R6和Z1如上定义; 在含有元素周期表中第12族金属元素的化合物存在下进行。

    IRIDIUM COMPLEXES
    7.
    发明申请
    IRIDIUM COMPLEXES 有权
    IRIDIUM复合物

    公开(公告)号:US20090036696A1

    公开(公告)日:2009-02-05

    申请号:US11660935

    申请日:2004-08-27

    IPC分类号: C07F15/00

    摘要: The present invention has as its object to provide an iridium complex represented by the general formula: [(l r H L1 L2)2(μ-X1)(μ-X2)(μ-X3)]X4  (1) (wherein L1 and L2 may be the same or different and each represent a monodendate neutral ligand, or each cooperate with the other to form a bidendate neutral ligand; X1, X2 and X3 may be the same or different, and each represent a halogen atom; and X4 is a counter-anion). Also, the present invention provides a novel catalyst which can achieve excellent performance as a catalyst for asymmetric synthesis, especially asymmetric hydrogenation, in terms of chemical selectivity, enantioselectivity and catalytic activity, and the like.

    摘要翻译: 本发明的目的是提供由以下通式表示的铱络合物:<?in-line-formula description =“In-line formula”end =“lead”?> [(lr H L1 L2)2(mu -X1)(mu-X2)(mu-X3)] X4(1)<?in-line-formula description =“In-line Formulas”end =“tail”?>(其中L1和L2可以相同或 各自代表一个单体中性配体,或者每个与另一个配位,以形成一种双羟纶中性配体; X 1,X 2和X 3可以相同或不同,各自表示卤素原子; X 4是抗衡阴离子)。 此外,本发明提供了一种新颖的催化剂,其在化学选择性,对映选择性和催化活性等方面可以获得作为不对称合成,特别是不对称氢化的催化剂的优异性能。

    Iridium complexes
    9.
    发明授权
    Iridium complexes 有权
    铱络合物

    公开(公告)号:US07642357B2

    公开(公告)日:2010-01-05

    申请号:US11660935

    申请日:2004-08-27

    IPC分类号: C07F15/00 B01J31/00

    摘要: The present invention has as its object to provide an iridium complex represented by the general formula: [(I r H L1 L2)2(μ−X1)(μ−X2)(μ−X3)]X4  (1) (wherein L1 and L2 may be the same or different and each represent a monodendate neutral ligand, or each cooperate with the other to form a bidendate neutral ligand; X1, X2 and X3 may be the same or different, and each represent a halogen atom; and X4 is a counter-anion). Also, the present invention provides a novel catalyst which can achieve excellent performance as a catalyst for asymmetric synthesis, especially asymmetric hydrogenation, in terms of chemical selectivity, enantioselectivity and catalytic activity, and the like.

    摘要翻译: 本发明的目的是提供由以下通式表示的铱络合物:[(I r H L1 L2)2(mu-X1)(mu-X2)(mu-X3)] X4(1)(其中L1 和L2可以相同或不同,并且各自表示单羟基中性配体,或者各自表示一个中性配位体,或者各自与另一个配位以形成双羟萘酸中性配体; X 1,X 2和X 3可以相同或不同,并且各自表示卤素原子; X 4 是抗衡阴离子)。 此外,本发明提供了一种新颖的催化剂,其在化学选择性,对映选择性和催化活性等方面可以获得作为不对称合成,特别是不对称氢化的催化剂的优异性能。